Načítá se...
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
There is a significant opportunity to improve cardiovascular disease (CVD) outcomes in lung cancer screening cohorts with a low-cost, noninvasive assessment of CVD risk, alongside existing assessments https://bit.ly/3a6Ha41
Uloženo v:
| Vydáno v: | Breathe (Sheff) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Respiratory Society
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792827/ https://ncbi.nlm.nih.gov/pubmed/33447290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0204-2020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|